Oregon-based Stonepine Capital Management sold all 38,597 shares of its ANI Pharmaceuticals shares in the third quarter. The shares were worth about $2.52 million. The move marked a full exit from ANI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results